Deutsche Tageszeitung - Novartis upgrades outlook despite US legal setback

Novartis upgrades outlook despite US legal setback


Novartis upgrades outlook despite US legal setback
Novartis upgrades outlook despite US legal setback / Photo: © AFP/File

Swiss pharmaceutical giant Novartis raised its earnings guidance for the second time this year on Tuesday despite a legal setback in the United States and announced it will spin off its generics unit later this year.

Change text size:

The company, which is focusing on its core pharmaceutical operations, said it plans to spin off its Sandoz generics unit at the beginning of the fourth quarter by listing its shares on the SIX Swiss stock exchange.

After the spinoff, Novartis will focus on five core therapeutic areas: cardiovascular, immunology, neuroscience, solid tumours and haematology.

During the second quarter, Novartis saw its net profits jump by 54 percent from the same period last year to $2.3 billion thanks to both rising sales and lower restructuring charges.

Sales rose by 9 percent during the April-June period to $13.6 billion, beating the analyst consensus of $13.2 billion established by Swiss financial news service AWP.

The pharmaceuticals division drove the increase in sales, rising by nine percent to $11.2 billion, as its leading drugs such as heart failure treatment Entresto enjoyed a strong performance.

Novartis said it would appeal a US court ruling invalidating its patent for Entresto and noted no generic version of the medication is on the market in the United States.

Chief executive Vas Narasimhan said the strong performance of its medications plus its pipeline of future drugs gives Novartis confidence over the medium term and enables it to raise its 2023 outlook for a second time.

It now expects sales growth in the high single digits for 2023, compared to mid-single digits previously. Core operating income is now expected to post a low double-digit increase, compared to high single digit growth.

The company's "robust balance sheet and expected future growth" allows it to return $15 billion to shareholders "while maintaining the flexibility for continued strategic bolt-on acquisitions," Narasimhan said in a statement.

Novartis shares were up 3.1 percent in afternoon trading.

(U.Stolizkaya--DTZ)

Featured

Langley Businesses Navigate Tariff Pressures Amid Holiday Shopping Push

Independent businesses in Langley are facing heightened financial pressures from recent tariff implementations as they navigate the crucial holiday shopping period. While supply chain disruptions threaten inventory and pricing, local advocates highlight that spending at community retailers recirculates significantly more wealth within the region than purchases made through multinational or online platforms.

ALIX LASERS shareholders remove Michael Sobitsch as managing director in view of the circumstances

In an interview with BERLINER TAGESZEITUNG, the shareholders of Alix Lasers GmbH in Austria said that, after acquiring 100 per cent of the company’s shares, they removed Michael Sobitsch from his position as managing director yesterday, 19 November 2026, in Vienna, Austria. In view of the circumstances, they removed him from office with immediate effect, without granting him discharge for his tenure as managing director.

Phoenix Apartment Complexes Offer Free Rent Promotions

Three apartment complexes in Phoenix are currently offering significant free rent incentives to attract new tenants. The promotions range from one month of free rent to up to 16 weeks, depending on the lease term and specific property. Listings were available as of mid-November for units across various price points.

Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year

Saudi Arabia's Public Investment Fund (PIF) has been named the world’s most valuable sovereign wealth fund brand for the third consecutive year, according to a new assessment by Brand Finance. The ranking highlights the fund's growing global influence and financial strength as it advances its strategic objectives under Vision 2030.

Change text size: